Coronary disease

Chronic Coronary Syndromes

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases...

Dr. Omar Tupayachi - 28 November, 2025

Learn More

Coronary disease

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary...

Dr. Andrés Rodríguez - 20 November, 2025

Learn More

Antiplatelet

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially...

Dr. Omar Tupayachi - 13 November, 2025

Learn More

Chronic Ischemic cardiopathy

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

LDL cholesterol is a well-established factor for cardiovascular disease. Therapy with PCSK9 inhibitors, including evolocumab, has been...

Dr. Omar Tupayachi - 13 November, 2025

Learn More

Antiplatelet

AHA 2025 | TUXEDO-2: Post-PCI Antiplatelet Management in Diabetic Patients with Multivessel Disease — Ticagrelor or Prasugrel?

Choosing the optimal P2Y12 inhibitor for diabetic patients with multivessel coronary artery disease undergoing percutaneous coronary intervention...

Dr. Omar Tupayachi - 12 November, 2025

Learn More

Coronary Disease

AHA 2025 | DECAF: Coffee Consumption vs. Abstinence in Patients with Atrial Fibrillation: Recurrence or Myth?

The link between coffee consumption and arrhythmia has been met with contradicting recommendations. It is widely believed...

Dr. Omar Tupayachi - 12 November, 2025

Learn More

Calcified Lesions

CALIPSO: Calcified Lesions and Use of OCT

Percutaneous coronary intervention (PCI) in calcified lesions remains one of the most challenging scenarios in daily practice,...

Dr. Omar Tupayachi - 10 November, 2025

Learn More

Coronary disease

Retrospective Analysis of DCB vs DES in Side-Branch Treatment

Coronary bifurcations are one of the most challenging scenarios in percutaneous coronary intervention (PCI) due to their...

Dr. Omar Tupayachi - 4 November, 2025

Learn More

Coronary disease

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

AHA 2025 | TUXEDO-2: Post-PCI Antiplatelet Management in Diabetic Patients with Multivessel Disease — Ticagrelor or Prasugrel?

AHA 2025 | DECAF: Coffee Consumption vs. Abstinence in Patients with Atrial Fibrillation: Recurrence or Myth?

CALIPSO: Calcified Lesions and Use of OCT

Retrospective Analysis of DCB vs DES in Side-Branch Treatment

Last News

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Is it really necessary to monitor all patients after TAVR?

Is it really necessary to monitor all patients after TAVR?

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Access